Senior insider sale
TG THERAPEUTICS, INC. — senior position signals high conviction
$489.5K
20K shares
What this filing means
ECHELARD YANN plans to sell 20K shares of TG THERAPEUTICS, INC. valued at approximately $489.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/5/2024ACC: 0001959173-24-007410
20K
Shares to sell
$489.5K
Approx. market value
20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
6/4/2024
11KOpen Market Purchase
Cash
1/6/2023
9KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/4/2024 | Restricted Stock Vesting Compensation | 11K | — |
1/6/2023 | Open Market Purchase Cash | 9K | — |
| Total | 20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20K
Market value
$489.5K
11/5/2024
Total
Units
20K
Value
$489.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/5/2024 | 20K | $489.5K | NASDAQ | Planned |
| Total | 20K | $489.5K | ||